Home > Cashflow Statement > CIPLA

CIPLA
Cashflow Statement

CIPLA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for CIPLA
Please provide your vote to see the results

CIPLA Last 5 Year Cashflow Statement History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Profit Before Tax₹5,224 Cr₹6,821 Cr₹5,897 Cr₹4,221 Cr₹3,675 Cr
Adjustment ₹528 Cr₹518 Cr₹641 Cr₹878 Cr₹967 Cr
Changes In working Capital ₹-225 Cr₹-665 Cr₹-806 Cr₹-559 Cr₹-177 Cr
Cash Flow after changes in Working Capital ₹5,526 Cr₹6,673 Cr₹5,731 Cr₹4,540 Cr₹4,465 Cr
Cash Flow from Operating Activities ₹3,940 Cr₹5,005 Cr₹4,134 Cr₹3,238 Cr₹3,326 Cr
Cash Flow from Investing Activities ₹-2,326 Cr₹-3,691 Cr₹-2,988 Cr₹-2,389 Cr₹-1,872 Cr
Cash Flow from Financing Activities ₹-1,234 Cr₹-1,293 Cr₹-1,200 Cr₹-958 Cr₹-1,600 Cr
Net Cash Inflow / Outflow ₹380 Cr₹21 Cr₹-55 Cr₹-109 Cr₹-146 Cr
Opening Cash & Cash Equivalents ₹543 Cr₹512 Cr₹561 Cr₹658 Cr₹790 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹93 Cr₹9.26 Cr₹5.56 Cr₹12 Cr₹13 Cr
Closing Cash & Cash Equivalent ₹1,015 Cr₹543 Cr₹512 Cr₹561 Cr₹658 Cr

Compare Cashflow Statement of peers of CIPLA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CIPLA ₹116,460.5 Cr -1.2% 4.7% -4.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹465,195.0 Cr 1.8% 9% 12.5% Stock Analytics
DIVIS LABORATORIES ₹180,823.0 Cr 0.8% 0.8% -1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹165,725.0 Cr 2.8% 9.5% 45.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,987.0 Cr -7.6% 0.1% 6.1% Stock Analytics
MANKIND PHARMA ₹104,544.0 Cr 0% 5.9% 4.3% Stock Analytics


CIPLA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CIPLA

-1.2%

4.7%

-4.4%

SENSEX

-1%

4.4%

-8.3%


You may also like the below Video Courses